Parallax Health Sciences Inc (PRLX) Financial Statements (2023 and earlier)
Company Profile
| Business Address |
1327 OCEAN AVENUE, SUITE M SANTA MONICA, CA 90401 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 80 - Health Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 6 | 12 | 16 | 2 | 0 | ||
| Cash and cash equivalents | 6 | 12 | 16 | 2 | 0 | ||
| Receivables | 25 | ||||||
| Prepaid expense | 9 | ||||||
| Other undisclosed current assets | 52 | 77 | 102 | ||||
| Total current assets: | 59 | 89 | 127 | 27 | 0 | ||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 2 | 2 | 3 | ||||
| Intangible assets, net (including goodwill) | 1,243 | 1,274 | 1,304 | 1,334 | 1,364 | ||
| Goodwill | 785 | 785 | 785 | 785 | 785 | ||
| Intangible assets, net (excluding goodwill) | 458 | 489 | 519 | 549 | 579 | ||
| Other undisclosed noncurrent assets | 56 | 1,008 | 8 | ||||
| Total noncurrent assets: | 1,301 | 2,284 | 1,314 | 1,334 | 1,364 | ||
| TOTAL ASSETS: | 1,360 | 2,373 | 1,441 | 1,361 | 1,364 | ||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 2,083 | 2,420 | 2,797 | 2,775 | 2,655 | ||
| Accounts payable | 1,128 | 1,015 | 1,011 | 858 | 831 | ||
| Accrued liabilities | 85 | 85 | 160 | 250 | |||
| Employee-related liabilities | 339 | 541 | 513 | 482 | 402 | ||
| Interest and dividends payable | 376 | 229 | 639 | 547 | 450 | ||
| Other undisclosed accounts payable and accrued liabilities | 240 | 550 | 549 | 727 | 722 | ||
| Debt | 2,587 | 1,040 | 964 | 1,099 | 1,348 | ||
| Derivative instruments and hedges, liabilities | 63 | 54 | 57 | ||||
| Due to related parties | 1,235 | 1,494 | 1,417 | 1,260 | 1,005 | ||
| Other undisclosed current liabilities | 1,755 | 204 | 513 | 492 | 132 | ||
| Total current liabilities: | 7,723 | 5,212 | 5,748 | 5,626 | 5,140 | ||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 760 | 597 | 744 | 977 | 975 | ||
| Long-term debt, excluding current maturities | 760 | 597 | 744 | 977 | 975 | ||
| Liabilities, other than long-term debt | 633 | 491 | 491 | 491 | |||
| Due to related parties | 633 | 491 | 491 | 491 | |||
| Other undisclosed noncurrent liabilities | 2,498 | 1,400 | 718 | 751 | 740 | ||
| Total noncurrent liabilities: | 3,892 | 1,997 | 1,953 | 2,219 | 2,206 | ||
| Total liabilities: | 11,614 | 7,209 | 7,701 | 7,846 | 7,346 | ||
| Stockholders' equity | |||||||
| Stockholders' equity attributable to parent, including: | (10,255) | (4,835) | (6,260) | (6,485) | (5,982) | ||
| Preferred stock | 1 | 1 | 1 | 1 | 1 | ||
| Common stock | 250 | 234 | 205 | 170 | 158 | ||
| Common stock, share subscribed but unissued, subscriptions receivable | (500) | (500) | |||||
| Additional paid in capital | 21,552 | 21,078 | 17,224 | 12,290 | 11,132 | ||
| Deferred compensation equity | (1,149) | ||||||
| Accumulated deficit | (32,057) | (25,649) | (23,189) | (18,946) | (17,272) | ||
| Other undisclosed stockholders' equity attributable to parent | 1,149 | ||||||
| Total stockholders' equity: | (10,255) | (4,835) | (6,260) | (6,485) | (5,982) | ||
| TOTAL LIABILITIES AND EQUITY: | 1,360 | 2,373 | 1,441 | 1,361 | 1,364 | ||
Income Statement (P&L) ($ in thousands) Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | ||
|---|---|---|---|---|---|---|
| Revenues | 51 | 26 | 1 | 51 | 1 | |
| Cost of revenue (Cost of Goods and Services Sold) | (4) | (4) | (4) | (5) | (5) | |
| Gross profit: | 47 | 22 | (3) | 46 | (4) | |
| Operating expenses | (1,302) | (1,938) | (1,733) | (1,456) | (1,350) | |
| Operating loss: | (1,255) | (1,916) | (1,736) | (1,410) | (1,354) | |
| Nonoperating expense | (5,153) | (544) | (719) | (264) | (610) | |
| Interest and debt expense | (470) | (150) | (193) | (100) | 23,261 | |
| Income (loss) from continuing operations before equity method investments, income taxes: | (6,878) | (2,610) | (2,648) | (1,774) | 21,297 | |
| Other undisclosed income (loss) from continuing operations before income taxes | (457) | 150 | 193 | 100 | (45) | |
| Income (loss) from continuing operations before income taxes: | (7,335) | (2,460) | (2,455) | (1,674) | 21,252 | |
| Other undisclosed income (loss) from continuing operations | 927 | (23,216) | ||||
| Net loss available to common stockholders, diluted: | (6,408) | (2,460) | (2,455) | (1,674) | (1,964) | |
Comprehensive Income ($ in thousands)Annual | Quarterly
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | ||
|---|---|---|---|---|---|---|
| Net loss: | (6,408) | (2,460) | (2,455) | (1,674) | (1,964) | |
| Comprehensive loss, net of tax, attributable to parent: | (6,408) | (2,460) | (2,455) | (1,674) | (1,964) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.